Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective, Observational Study to Evaluate the Safety and Efficacy of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

NCT07678177 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

NCT NCT07678177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07678177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective, Observational Study to Evaluate the Safety and Efficacy of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients
Lead sponsor
HK inno.N Corporation
Phase
Observational
Overall status
Recruiting
Start date
March 7, 2023
Completion date
June 30, 2027
Enrollment
5,384 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd (gastroesophageal reflux disease)